+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Enzyme-Linked Immunosorbent Assay Service Market - Global Forecast 2025-2030- Product Image
Enzyme-Linked Immunosorbent Assay Service Market - Global Forecast 2025-2030- Product Image
Sale

Enzyme-Linked Immunosorbent Assay Service Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 190 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6118477
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Enzyme-linked immunosorbent assay (ELISA) services occupy an essential position in biomedical research and diagnostics, supporting critical applications ranging from disease mechanism elucidation to pharmaceutical development. For senior decision-makers navigating a dynamic market, understanding key trends, evolving regulation, and regional complexities is vital to strategic success.

Market Snapshot: ELISA Services Market Overview

The global ELISA services market is experiencing robust growth, propelled by the escalating adoption of sensitive and specific immunoassays across life sciences and clinical settings. Market size and annual growth rates reflect increasing investment in modern assay platforms and advanced detection methodologies, underpinning widespread expansion in research, diagnostic, and pharmaceutical applications. Companies are strategically differentiating through innovation, automation, and scalable operational models to capture larger market shares and respond to surging end-user demands.

Scope & Segmentation of the ELISA Services Market

  • Assay Types: Includes competitive, direct, indirect, and sandwich formats, each offering distinct advantages in terms of speed, specificity, and sensitivity.
  • Detection Methods: Covers chemiluminescent, colorimetric, and fluorescent approaches, spanning routine to high-sensitivity and multiplexing workflows.
  • End Users: Encompasses academic and research institutes, contract research organizations, hospitals and diagnostic laboratories, and pharmaceutical or biotechnology companies.
  • Sample Types: Services address plasma, serum, and urine specimens, each presenting unique preanalytical and matrix considerations for providers.
  • Applications: Spans disease diagnostics, drug discovery and validation, quality control processes, and broader research purposes.
  • Regions Covered:
    • Americas (United States – including California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada; Mexico; Brazil; Argentina)
    • Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland)
    • Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Leading Companies: Laboratory Corporation of America Holdings, IQVIA Holdings Inc., Thermo Fisher Scientific Inc., ICON plc, Charles River Laboratories International, PAREXEL International Corporation, Syneos Health Inc., Eurofins Scientific SE, SGS SA, WuXi AppTec Co., Ltd.

Key Takeaways for Decision-Makers

  • Specialized ELISA solutions continue to evolve, allowing end users to address increasingly complex biomedical questions through diverse assay formats and detection technologies.
  • The rise of multiplexing and microfluidic platforms is expanding assay efficiency and reducing reagent consumption, promoting scalable and cost-effective testing workflows for research and clinical laboratories.
  • Technological advancements in chemiluminescent and fluorescent detection methods are pushing the boundaries of analytical sensitivity, enabling robust quantification even in low-abundance biomarker studies.
  • Regional differentiation remains strong, with localized reagent manufacturing and service hubs enhancing supply chain stability and customer responsiveness, particularly in light of shifting global trade conditions.
  • Service portfolios are increasingly tailored by end-user needs, integrating workflow automation, data analytics, and compliance-focused quality management to sustain competitive positioning.

Tariff Impact: 2025 U.S. Trade Policy Dynamics

The introduction of new United States tariffs in 2025 has significantly influenced the global ELISA service supply chain, especially for imported antibodies, enzymes, and instrumentation. Providers have responded by expanding domestic sourcing, establishing regional manufacturing facilities, and adopting miniaturized, reagent-efficient assay formats to offset rising operational costs. These adjustments are fostering greater resilience and agility across the sector.

Methodology & Data Sources

This report leverages a multi-level research methodology, including qualitative interviews with executives from leading ELISA service and reagent providers, complemented by analysis of secondary sources such as scientific literature, industry publications, and regulatory guidance. A systematic triangulation approach ensures accurate, up-to-date insights relevant to current market dynamics.

Why This Report Matters to Industry Leaders

  • Enables senior executives to proactively address shifting demand drivers, invest in innovation, and tailor offerings for maximum impact within the ELISA services market.
  • Supports strategic planning amid evolving regulatory frameworks, regional trade policies, and advancing assay technologies.
  • Delivers actionable guidance for mitigating supply chain risks, enhancing data reliability, and capturing emerging growth opportunities.

Conclusion

Continuous innovation, targeted partnerships, and rigorous quality systems characterize the future of ELISA services. This report equips decision-makers with the context and insights required to navigate change, optimize service portfolios, and achieve strong market positioning.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Emergence of multiplexed ELISA assays enabling simultaneous detection of multiple cytokines and biomarkers
5.2. Integration of digital immunoassay platforms with AI-driven data analytics for enhanced diagnostic accuracy
5.3. Growing demand for point-of-care ELISA testing in decentralized healthcare and remote patient monitoring
5.4. Rising utilization of recombinant antigen-based ELISA kits for improved specificity in infectious disease diagnosis
5.5. Advancement of microfluidic ELISA platforms for rapid, low-volume immunoassay applications in clinical settings
5.6. Increasing adoption of label-free optical detection techniques in ELISA for real-time kinetic analysis of biomolecular interactions
5.7. Expansion of contract research organizations offering customized ELISA service solutions for biopharmaceutical development
5.8. Surge in demand for ELISA-based immunogenicity testing to support biologics and biosimilar regulatory submissions
5.9. Development of novel nanomaterial-enhanced ELISA assays to boost sensitivity and reduce assay time
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Enzyme-Linked Immunosorbent Assay Service Market, by Assay Type
8.1. Introduction
8.2. Competitive
8.3. Direct
8.4. Indirect
8.5. Sandwich
9. Enzyme-Linked Immunosorbent Assay Service Market, by Detection Method
9.1. Introduction
9.2. Chemiluminescent
9.3. Colorimetric
9.4. Fluorescent
10. Enzyme-Linked Immunosorbent Assay Service Market, by End User
10.1. Introduction
10.2. Academic And Research Institutes
10.3. Contract Research Organizations
10.4. Hospitals And Diagnostic Laboratories
10.5. Pharmaceutical And Biotechnology Companies
11. Enzyme-Linked Immunosorbent Assay Service Market, by Sample Type
11.1. Introduction
11.2. Plasma
11.3. Serum
11.4. Urine
12. Enzyme-Linked Immunosorbent Assay Service Market, by Application
12.1. Introduction
12.2. Disease Diagnostics
12.3. Drug Discovery
12.4. Quality Control
12.5. Research Purposes
13. Americas Enzyme-Linked Immunosorbent Assay Service Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Enzyme-Linked Immunosorbent Assay Service Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Enzyme-Linked Immunosorbent Assay Service Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Laboratory Corporation of America Holdings
16.3.2. IQVIA Holdings Inc.
16.3.3. Thermo Fisher Scientific Inc.
16.3.4. ICON plc
16.3.5. Charles River Laboratories International, Inc.
16.3.6. PAREXEL International Corporation
16.3.7. Syneos Health, Inc.
16.3.8. Eurofins Scientific SE
16.3.9. SGS SA
16.3.10. WuXi AppTec Co., Ltd.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY ASSAY TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY ASSAY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY DETECTION METHOD, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY DETECTION METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET: RESEARCHAI
FIGURE 26. ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET: RESEARCHSTATISTICS
FIGURE 27. ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET: RESEARCHCONTACTS
FIGURE 28. ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY COMPETITIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY COMPETITIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY DIRECT, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY DIRECT, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY INDIRECT, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY INDIRECT, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY SANDWICH, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY SANDWICH, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY CHEMILUMINESCENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY CHEMILUMINESCENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY COLORIMETRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY COLORIMETRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY FLUORESCENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY FLUORESCENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY PLASMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY PLASMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY SERUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY SERUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY URINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY URINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY DISEASE DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY DISEASE DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY QUALITY CONTROL, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY QUALITY CONTROL, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY RESEARCH PURPOSES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY RESEARCH PURPOSES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 67. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 68. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 69. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 70. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 79. CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 80. CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 81. CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 82. CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 83. CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 84. CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 85. CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 86. CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 87. CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 88. CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 89. MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 90. MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 91. MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 92. MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 93. MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 94. MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 95. MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 96. MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 97. MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 98. MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 99. BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 100. BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 101. BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 102. BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 103. BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 104. BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 105. BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 106. BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 107. BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 108. BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 109. ARGENTINA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 110. ARGENTINA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 111. ARGENTINA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 112. ARGENTINA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 113. ARGENTINA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. ARGENTINA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. ARGENTINA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 116. ARGENTINA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 117. ARGENTINA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 118. ARGENTINA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 131. UNITED KINGDOM ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 132. UNITED KINGDOM ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 133. UNITED KINGDOM ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 134. UNITED KINGDOM ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 135. UNITED KINGDOM ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. UNITED KINGDOM ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. UNITED KINGDOM ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 138. UNITED KINGDOM ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 140. UNITED KINGDOM ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 141. GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 142. GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 143. GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 144. GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 145. GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 148. GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 149. GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 150. GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 151. FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 152. FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 153. FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 154. FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 155. FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 158. FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 159. FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 160. FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 161. RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 162. RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 163. RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 164. RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 165. RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 168. RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 169. RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 170. RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 171. ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 172. ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 173. ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 174. ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 175. ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 178. ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 179. ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 180. ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 181. SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 182. SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 183. SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 184. SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 185. SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 186. SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 187. SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 188. SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 189. SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 190. SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 191. UNITED ARAB EMIRATES ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 192. UNITED ARAB EMIRATES ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 193. UNITED ARAB EMIRATES ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 194. UNITED ARAB EMIRATES ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 195. UNITED ARAB EMIRATES ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. UNITED ARAB EMIRATES ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. UNITED ARAB EMIRATES ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 198. UNITED ARAB EMIRATES ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 199. UNITED ARAB EMIRATES ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 200. UNITED ARAB EMIRATES ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 202. SAUDI ARABIA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 203. SAUDI ARABIA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 204. SAUDI ARABIA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 205. SAUDI ARABIA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. SAUDI ARABIA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. SAUDI ARABIA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 208. SAUDI ARABIA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 209. SAUDI ARABIA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 210. SAUDI ARABIA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 211. SOUTH AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 212. SOUTH AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 213. SOUTH AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 214. SOUTH AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 215. SOUTH AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. SOUTH AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. SOUTH AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 218. SOUTH AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 219. SOUTH AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 220. SOUTH AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 221. DENMARK ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 222. DENMARK ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 223. DENMARK ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 224. DENMARK ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 225. DENMARK ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. DENMARK ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. DENMARK ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 228. DENMARK ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 229. DENMARK ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 230. DENMARK ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 231. NETHERLANDS ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 232. NETHERLANDS ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 233. NETHERLANDS ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 234. NETHERLANDS ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 235. NETHERLANDS ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. NETHERLANDS ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. NETHERLANDS ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 238. NETHERLANDS ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 239. NETHERLANDS ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 240. NETHERLANDS ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 241. QATAR ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 242. QATAR ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 243. QATAR ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 244. QATAR ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 245. QATAR ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. QATAR ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. QATAR ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 248. QATAR ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 249. QATAR ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 250. QATAR ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 251. FINLAND ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 252. FINLAND ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 253. FINLAND ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 254. FINLAND ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 255. FINLAND ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. FINLAND ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. FINLAND ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 258. FINLAND ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 259. FINLAND ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 260. FINLAND ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 261. SWEDEN ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 262. SWEDEN ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 263. SWEDEN ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 264. SWEDEN ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 265. SWEDEN ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. SWEDEN ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. SWEDEN ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 268. SWEDEN ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 269. SWEDEN ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 270. SWEDEN ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 271. NIGERIA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 272. NIGERIA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 273. NIGERIA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 274. NIGERIA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 275. NIGERIA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 276. NIGERIA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 277. NIGERIA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 278. NIGERIA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 279. NIGERIA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 280. NIGERIA ENZYME-LINKED IMMUNOSORBENT ASSAY SERVICE MARKET SIZE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Enzyme-Linked Immunosorbent Assay Service market report include:
  • Laboratory Corporation of America Holdings
  • IQVIA Holdings Inc.
  • Thermo Fisher Scientific Inc.
  • ICON plc
  • Charles River Laboratories International, Inc.
  • PAREXEL International Corporation
  • Syneos Health, Inc.
  • Eurofins Scientific SE
  • SGS SA
  • WuXi AppTec Co., Ltd.

Related Topics

Related Reports

Enzyme-linked Immunosorbent Assay Testing Market - Global Forecast 2025-2030 - Product Image

Enzyme-linked Immunosorbent Assay Testing Market - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Enzyme-Linked Immunosorbent Assay (ELISA) Analyzers Global Market Report 2025 - Product Image

Enzyme-Linked Immunosorbent Assay (ELISA) Analyzers Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Enzyme-linked Immunosorbent Assay (Elisa) Testing - Global Strategic Business Report - Product Image

Enzyme-linked Immunosorbent Assay (Elisa) Testing - Global Strategic Business Report

  • Report
  • 163 Pages
  • Global
From
Enzyme-Linked Immunosorbent Assay Testing Market Report 2025 - Product Image

Enzyme-Linked Immunosorbent Assay Testing Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Research ELISA (Enzyme-Linked Immunosorbent Assay) - Global Strategic Business Report - Product Image

Research ELISA (Enzyme-Linked Immunosorbent Assay) - Global Strategic Business Report

  • Report
  • 266 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.